Drugs / 13C6-Glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06930976 | Oct 2025 → Jun 2027 expected | glucose metabolism disease, immune system disorder | Vanderbilt University Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C6-Glucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06930976 ↗ |
| Route | Intravenous | “given IV over 2-4 hours” NCT06930976 ↗ |